Why insider trading matters?
Numerous studies have examined whether there is evidence that U.S. insiders systematically trade on private information despite the legal deterrence. The consensus appears to be that insider purchases (but not sales) tend to be followed by positive abnormal stock price performance, particularly for small growth stocks.
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, provides novel therapeutics to treat retinal diseases. Its preclinical stage product candidate include KSI-501, a bispecific anti-interleukin 6/VEGF bioconjugate to target inflammation and abnormal angiogenesis in the pathogenesis of retinal vascular diseases. The company's early research pipeline include KSI-601, a triplet inhibitor for dry AMD. The company was formerly known as Oligasis, LLC and changed its name to Kodiak Sciences Inc. in September 2015.
| Trade Date | Insider | Title | Buy/Sell | #Shares | Price | Value | Option |
|---|---|---|---|---|---|---|---|
| 2022-06-06 | BAKER BROS. ADVISORS LP | 10%-Owner, Director | Buy | 572,349 | $7.77 | $4,448,168 | No |
| 2022-05-27 | BAKER BROS. ADVISORS LP | 10%-Owner, Director | Buy | 350,406 | $6.75 | $2,363,748 | No |
| 2022-05-18 | BAKER BROS. ADVISORS LP | 10%-Owner, Director | Buy | 456,690 | $5.91 | $2,696,829 | No |
| 2022-02-25 | PERLROTH VICTOR | Chairman and CEO | Sell | 1,340,000 | $9.15 | $12,257,688 | No |
| 2022-02-17 | BAKER BROS. ADVISORS LP | 10%-Owner, Director | Buy | 400,965 | $54.45 | $21,832,153 | No |
| 2022-01-31 | BAKER BROS. ADVISORS LP | 10%-Owner, Director | Buy | 347,665 | $52.02 | $18,084,687 | No |
| 2022-01-25 | BAKER BROS. ADVISORS LP | 10%-Owner, Director | Buy | 501,111 | $57.49 | $28,806,796 | No |
| 2021-12-20 | EHRLICH JASON | nan | Sell | 6,950 | $87.60 | $608,831 | Yes |
| 2021-11-10 | BORGESON JOHN A. | nan | Sell | 876 | $115.42 | $101,111 | No |
| 2021-10-20 | EHRLICH JASON | nan | Sell | 6,950 | $111.77 | $776,824 | Yes |
| 2021-09-30 | BAKER BROS. ADVISORS LP | 10%-Owner, Director | Buy | 86,932 | $95.83 | $8,330,572 | Yes |
| 2021-09-20 | EHRLICH JASON | nan | Sell | 6,950 | $99.88 | $694,164 | Yes |
| 2021-09-16 | BAKER BROS. ADVISORS LP | 10%-Owner, Director | Buy | 31,838 | $94.39 | $3,005,281 | No |
| 2021-09-07 | BAKER BROS. ADVISORS LP | 10%-Owner, Director | Buy | 57,501 | $93.31 | $5,365,227 | No |
| 2021-08-20 | EHRLICH JASON | nan | Sell | 6,950 | $91.44 | $635,534 | Yes |
| 2021-08-13 | BAKER BROS. ADVISORS LP | 10%-Owner, Director | Buy | 102,773 | $87.19 | $8,960,623 | No |
| 2021-06-21 | EHRLICH JASON | nan | Sell | 6,950 | $84.90 | $590,085 | No |
| 2021-06-15 | EHRLICH JASON | nan | Sell | 1,454 | $80.90 | $117,624 | Yes |
| 2021-06-15 | BORGESON JOHN A. | nan | Sell | 1,290 | $80.90 | $104,361 | Yes |
| 2021-06-15 | EHRLICH JASON | nan | Sell | 1,147 | $84.75 | $97,208 | Yes |
| 2021-06-15 | BORGESON JOHN A. | nan | Sell | 1,037 | $84.75 | $87,886 | Yes |
| 2021-05-20 | EHRLICH JASON | nan | Sell | 6,950 | $81.14 | $563,924 | No |
| 2021-04-20 | EHRLICH JASON | nan | Sell | 6,950 | $111.26 | $773,249 | Yes |
| 2021-03-22 | EHRLICH JASON | nan | Sell | 6,950 | $131.50 | $913,894 | Yes |
| 2021-03-10 | BORGESON JOHN A. | nan | Sell | 5,000 | $130.08 | $650,415 | No |
| 2021-02-22 | EHRLICH JASON | nan | Sell | 6,950 | $125.81 | $874,367 | Yes |
| 2021-01-20 | EHRLICH JASON | nan | Sell | 26,950 | $162.77 | $4,386,776 | Yes |
| 2020-12-23 | EHRLICH JASON | nan | Sell | 6,950 | $144.55 | $1,004,610 | Yes |
| 2020-11-20 | EHRLICH JASON | nan | Sell | 6,950 | $138.79 | $964,601 | Yes |
| 2020-11-20 | BAKER BROS. ADVISORS LP | 10%-Owner, Director | Buy | 1,527,777 | $108.00 | $164,999,916 | No |
Insider Smart
Insider Smart